Royalty Pharma
Ms. Lin joined Royalty Pharma in 2019. Previously, Ms. Lin was a Director of Technical Accounting & SEC Reporting at Shutterfly. Prior to that, Ms. Lin was an Audit Senior Manager with Ernst & Young LLP, with a focus on technology companies. Ms. Lin has a BS, summa cum laude, and an MS in accounting from Arizona State University and is a Certified Public Accountant.
Royalty Pharma
3 followers
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies.